Summary of Key Information:

Reporting Period (Quarter/Year): Quarter ended 30 June 2026 (Q1 FY27)

Nature of Filing / Announcement: Outcome of Board Meeting under Regulation 30 & 33 of SEBI LODR

Audit Opinion:

Unmodified Limited Review Reports issued by M/s. S.R.Batliboi & Associates LLP, Chartered Accountants

Key Financial Highlights [₹ in crores]:

Standalone Results:

Revenue from Operations: ₹955.66 (Q1 FY27) vs ₹900.67 (Q1 FY26) - 6.1% YoY increase

Total Income: Not explicitly specified in standalone breakdown

EBITDA: Not explicitly disclosed

Net Profit: ₹21.75 (Q1 FY27) vs ₹62.36 (Q1 FY26) - 65.1% YoY decrease

EPS: ₹6.74 (Basic and Diluted)

Other Equity: Not specified

Cash and Cash Equivalents: Not specified

Debt: Not specified

Consolidated Results:

Revenue from Operations: ₹1,197.94 (Q1 FY27) vs ₹1,006.87 (Q1 FY25) - 18.9% YoY increase

Total Income: ₹1,211.52 (Q1 FY27) vs ₹1,023.79 (Q1 FY25)

EBITDA: Not explicitly disclosed

Net Profit: ₹40.64 (Q1 FY27) vs ₹62.87 (Q1 FY25) - 35.4% YoY decrease

Attribution: Entirely attributable to shareholders of the company

EPS: ₹6.74 (Basic and Diluted)

Other Equity: Not specified

Cash and Cash Equivalents: Not specified

Debt: Not specified

Segment-wise Performance:

Based on internal reporting to Chief Operating Decision Maker, the consolidated financial results relate to "Milk and Milk Products" as the only reportable primary segment.

Geographical Revenue Breakdown [₹ in crores]:

India: ₹1,042.46 (Q1 FY27) vs ₹900.46 (Q1 FY25)

Outside India: ₹155.48 (Q1 FY27) vs ₹106.41 (Q1 FY25)

Non-current Assets Breakdown [₹ in crores]:

India: ₹1,242.96 (Q1 FY27)

Outside India: ₹117.09 (Q1 FY27)

Corporate Actions:

Dividend: Final dividend of ₹5 per equity share (face value ₹10 each) aggregating ₹30.16 crores was recommended on 16 May 2026 and approved by shareholders at AGM on 14 July 2026.

Other Significant Information:

Acquisition Approved:

Board approved acquisition of 2% of issued and paid-up equity share capital of Sids Farm Private Limited (CIN: U15200TG2016PTC111307) for cash consideration of ₹11,64,56,733 (₹4,203 per share).

Target Company Details:

Sids Farm Private Limited is engaged in manufacturing and sale of milk and dairy products with paid-up share capital of ₹1,32,49,601. Turnover: FY25-26 ₹240 crore (unaudited), FY24-25 ₹169.77 crore (audited), FY23-24 ₹122.50 crore (audited).

Investment Rationale:

Strategic minority investment in a premium, antibiotic- and hormone-free dairy brand with strong multi-region direct-to-consumer (D2C) and e-commerce presence. Complements company's established market dairy operations and provides exposure to fast-growing premium D2C dairy segment.

Transaction Details:

Not a related party transaction. Funded from internal accruals. No material impact on financial position, net worth, results of operations, control or management. Expected completion within approximately one month from execution of definitive agreements.

Entities in Consolidation:

Holding Company:

Dodla Dairy Limited

Subsidiaries:

Dodla Holdings Pte Limited, Singapore

Lakeside Dairy Limited, Uganda

Dodla Dairy Kenya Limited, Kenya

Orgafeed Private Limited, India

Country Delight Dairy Limited, Kenya

HR Food Processing Private Limited, India (with effect from August 01, 2025)

Associate:

Global VetMed Concepts India Private Limited, India

Subsidiaries contributed total revenues of ₹210.28 crores and total net profit after tax of ₹18.23 crores for the quarter ended June 30, 2026.